X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

CMPX

Closed

Compass Therapeutics Inc.

2.58
-0.02 (-0.77%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 2.6
Day's Range: 2.5 - 2.67
Send
When Written:
 
3.27
Compass Therapeutics Inc. is a clinical-stage biotechnology company that develops targeted antibody therapies for cancer and autoimmune diseases. The company was founded in 2014 and is headquartered in Boston, Massachusetts. Compass Therapeutics uses a proprietary platform called Targeted Immunomodulation to discover and develop monoclonal antibodies that selectively modulate the immune system to treat diseases. The company's pipeline includes multiple drug candidates in various stages of development for the treatment of cancer, including solid tumors and hematologic malignancies, as well as autoimmune diseases such as psoriasis and rheumatoid arthritis. Compass Therapeutics has partnerships with multiple pharmaceutical companies and research institutions to advance its drug development programs.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.11
X